Global Information
회사소개 | 문의 | 비교리스트

세계의 중합효소 연쇄 반응(PCR) 시장 예측

Global Polymerase Chain Reaction Market Forecast 2019-2027

리서치사 Inkwood Research
발행일 2019년 05월 상품 코드 837254
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,621,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,431,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 중합효소 연쇄 반응(PCR) 시장 예측 Global Polymerase Chain Reaction Market Forecast 2019-2027
발행일 : 2019년 05월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 중합효소 연쇄 반응(PCR : Polymerase Chain Reaction) 시장에 대해 조사 분석했으며, 시장 개요, 부문별 시장 분석, 지역별 분석, 경쟁 상황, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 범위와 정의
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 과제

제5장 시장 : 기술별

  • 실시간 PCR
  • 기존 PCR
  • 디지털 PCR

제6장 시장 : 제품별

  • 시약 및 소모품
  • 장비
  • 소프트웨어
  • 서비스

제7장 시장 : 용도별

  • 임상
  • 연구
  • 법의학

제8장 시장 : 최종사용자별

  • 진단 센터 및 병원
  • 바이오테크놀러지 및 제약 기업
  • 학술 및 연구기관

제9장 주요 애널리틱스

  • Porter's Five Forces 모델
  • 기회 매트릭스
  • 벤더 상황

제10장 지역별 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 기타

제11장 경쟁 상황

  • 기업 개요
    • AGILENT TECHNOLOGIES INC.
    • BIORAD TECHNOLOGIES INC.
    • QIAGEN N.V.
    • F. HOFFMAN LA ROCHE LTD.
    • THERMOFISHER SCIENTIFIC INC.
    • ABBOTT LABORATORIES
    • BECTON DICKINSON BIOSCIENCES SYSTEMS AND REAGENTS INC.
    • SIEMENS HEALTHINEERS
    • BIOMERIEUX SA
    • DANAHER CORPORATION
    • MDXHEALTH CORPORATION
    • NANO BIOSYS INC.
    • TAHARA BIO INC.
    • FLUIDIGM CORPORATION
    • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
KSM 19.05.28

LIST OF TABLES

  • TABLE 1. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
  • TABLE 2. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)
  • TABLE 3. GLOBAL PCR MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)
  • TABLE 4. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)
  • TABLE 5. GLOBAL REAGENT AND CONSUMABLES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 7. GLOBAL SOFTWARE MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 8. GLOBAL SERVICES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 9. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY APPLICATION, 2019-2027, (IN $ MILLION)
  • TABLE 10. GLOBAL CLINICAL MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 11. GLOBAL RESEARCH MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 12. GLOBAL FORENSICS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 13. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY END USER 2019-2027, (IN $ MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC CENTERS & HOSPITALS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 15. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 16. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 17. OPPORTUNITY MATRIX
  • TABLE 18. VENDOR LANDSCAPE
  • TABLE 19. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)
  • TABLE 20. NORTH AMERICA POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 21. EUROPE POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 22. ASIA PACIFIC POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 23. REST OF WORLD POLYMERASE CHAIN (PCR) MARKET, BY REGION, 2019-2027 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TYPE, 2018 & 2027 (IN %)
  • FIGURE 2. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)
  • FIGURE 3. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TRADITIONAL PCR, 2019-2027 (IN $ MILLION)
  • FIGURE 4. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 (IN $ MILLION)
  • FIGURE 5. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
  • FIGURE 6. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY SOFTWARE, 2019-2027 (IN $ MILLION)
  • FIGURE 7. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY SERVICES, 2019-2027 (IN $ MILLION)
  • FIGURE 8. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY CLINICAL, 2019-2027 (IN $ MILLION)
  • FIGURE 9. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY RESEARCH, 2019-2027 (IN $ MILLION)
  • FIGURE 10. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY FORENSICS, 2019-2027 (IN $ MILLION)
  • FIGURE 11. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY DIAGNOSTIC CENTERS & HOSPITALS, 2019-2027 (IN $ MILLION)
  • FIGURE 12. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY BIOTECH & PHARMA COMPANIES, 2019-2027 (IN $ MILLION)
  • FIGURE 13. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
  • FIGURE 14. PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 15. GLOBAL POLYMERASE CHAIN (PCR) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 16. UNITED STATES POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 17. CANADA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 18. UNITED KINGDOM POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 19. GERMANY POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 20. FRANCE POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 21. SPAIN POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 22. ITALY POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 23. REST OF EUROPE POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 24. CHINA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 25. JAPAN POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 26. INDIA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 27. SOUTH KOREA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 28. AUSTRALIA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 29. REST OF ASIA PACIFIC POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 30. LATIN AMERICA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 31. MIDDLE EAST & AFRICA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

KEY FINDINGS

Global polymerase chain reaction market refers to the method that produces abundant copies of a target DNA region in vitro. This chain reaction depends on a thermostable DNA polymerase called TAQ polymerase, which is extracted from Thermus aquaticus and as the name suggests, they live in hot springs and hydrothermal vents.

Global polymerase chain reaction market generated a revenue of $XX billion in 2018 & is projected to reach $13,644 million by 2027, at a CAGR of 6.19% during the forecasting years of 2019-2027. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027.

MARKET INSIGHTS

Global polymerase chain reaction market is primarily driven by increasing prevalence of infectious diseases and the growing geriatric population. The increasing investments by the key players coupled with rapid changes in technology are the prime factors which are fueling the growth of the market.

With the growing acceptance of polymerase chain reaction techniques, the global market is also facing some challenges. The inability of the conventional PCR technique to target complex endpoint sequences is limiting the growth of the PCR in the forecast period. The availability of alternative technologies for DNA sequencing is also probing as a challenge to the market in the coming years. Moreover, the high cost of instruments and the high cost of labor is further obstructing the growth of the global market.

Also, the increasing collaborations and mergers between key players for launching innovative products with more efficient polymerase chain reaction techniques will further fuel the market growth in the future.

REGIONAL INSIGHTS

Report scope of the global polymerase chain reaction market covers segmentation by several regions, namely, North America, Asia Pacific, Europe and the remaining countries collectively forming the Rest of World regional segment.

The North America polymerase chain reaction market is rising rapidly owing to the rising occurrence rate of infectious and chronic diseases such as the likes of HIV/AIDS, hepatitis, and cancer in concurrence with an increasing number of R&D activities by biotechnological & pharmaceutical companies in the region. The increasing laboratory usage for PCR in the region coupled with new product developments in the region is boosting the growth of the North America polymerase chain reaction market.

COMPETITIVE INSIGHTS

Becton Dickinson Biosciences Systems and Reagents Inc., Abbott Laboratories, Qiagen N.V., Biomerieux SA, Fluidigm Corporation, Danaher Corporation, Siemens Healthineers, MDXhealth Corporation, Agilent Technologies Inc., Pacific Biosciences of California, Inc., Nano Biosys Inc., Bio-Rad Technologies Inc., Tahara Bio Inc., Thermo Fisher Scientific Inc., and F. Hoffman La Roche Ltd. are the major companies operating in the market which have been thoroughly outlined in the report.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REAGENTS AND CONSUMABLES HOLDS THE LARGEST MARKET SHARE
    • 3.2.2. RISE IN INFECTIOUS DISEASES WORLDWIDE
    • 3.2.3. INCREASING DEMAND FOR DIGITAL PCR

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISING INCIDENCES OF INFECTIONS AND DISEASES
    • 4.2.2. DEVELOPMENT IN PHARMACOGENOMICS
    • 4.2.3. EMERGENCE OF DIGITAL PCR
    • 4.2.4. INCREASING PUBLIC-PRIVATE INVESTMENTS AND GRANTS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. NON-VALIDATED HOME BREW TESTS
    • 4.3.2. HIGH DEVICE COSTS ASSOCIATED WITH PCR
    • 4.3.3. NECESSITY OF TRAINING AND UPDATION OF LABORATORIES WORKERS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. RISE IN FUNDING OF GENE AND HUMAN GENOME PROJECTS
    • 4.4.2. EXPANDING HEALTHCARE MARKET IN APAC
  • 4.5. MARKET CHALLENGES
    • 4.5.1. INACCURACY CAUSED BY THE PCR TECHNIQUES
    • 4.5.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES

5. MARKET BY TECHNOLOGY

  • 5.1. REAL-TIME PCR
  • 5.2. TRADITIONAL PCR
  • 5.3. DIGITAL PCR

6. MARKET BY PRODUCT

  • 6.1. REAGENT AND CONSUMABLES
  • 6.2. INSTRUMENTS
  • 6.3. SOFTWARE
  • 6.4. SERVICES

7. MARKET BY APPLICATION

  • 7.1. CLINICAL
  • 7.2. RESEARCH
  • 7.3. FORENSICS

8. MARKET BY END-USER

  • 8.1. DIAGNOSTIC CENTERS & HOSPITALS
  • 8.2. BIOTECH & PHARMA COMPANIES
  • 8.3. ACADEMIC AND RESEARCH INSTITUTES

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCE MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF SUPPLIERS
    • 9.1.4. BARGAINING POWER OF BUYERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. OPPORTUNITY MATRIX
  • 9.3. VENDOR LANDSCAPE

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. UNITED STATES
    • 10.1.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. UNITED KINGDOM
    • 10.2.2. GERMANY
    • 10.2.3. FRANCE
    • 10.2.4. SPAIN
    • 10.2.5. ITALY
    • 10.2.6. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. CHINA
    • 10.3.2. JAPAN
    • 10.3.3. INDIA
    • 10.3.4. SOUTH KOREA
    • 10.3.5. AUSTRALIA
    • 10.3.6. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. LATIN AMERICA
    • 10.4.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. COMPANY PROFILES
    • 11.1.1. AGILENT TECHNOLOGIES INC.
    • 11.1.2. BIORAD TECHNOLOGIES INC.
    • 11.1.3. QIAGEN N.V.
    • 11.1.4. F. HOFFMAN LA ROCHE LTD.
    • 11.1.5. THERMOFISHER SCIENTIFIC INC.
    • 11.1.6. ABBOTT LABORATORIES
    • 11.1.7. BECTON DICKINSON BIOSCIENCES SYSTEMS AND REAGENTS INC.
    • 11.1.8. SIEMENS HEALTHINEERS
    • 11.1.9. BIOMERIEUX SA
    • 11.1.10. DANAHER CORPORATION
    • 11.1.11. MDXHEALTH CORPORATION
    • 11.1.12. NANO BIOSYS INC.
    • 11.1.13. TAHARA BIO INC.
    • 11.1.14. FLUIDIGM CORPORATION
    • 11.1.15. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Back to Top
전화 문의
F A Q